Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Initiation of Translation02:33

Initiation of Translation

39.1K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
39.1K
Initiation of Translation02:33

Initiation of Translation

8.1K
8.1K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

371
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
371
Transcription Initiation01:47

Transcription Initiation

21.2K
Initiation is the first step of transcription in eukaryotes. Prokaryotic RNA Polymerase (RNAP) can bind to the template DNA and start transcribing. On the other hand, transcription in eukaryotes requires additional proteins, called transcription factors, to first bind to the promoter region in the DNA template. This binding helps recruit the specific RNAP that can assemble on the DNA and start transcription.
The promoters and enhancers and their accessory proteins allow tight regulation of...
21.2K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

585
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
585
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

349
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
349

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Potential for a Benefit-Estimating Algorithm to Improve Recommendations for Preventive Services: Comparing Algorithm Recommendations with Those of Primary Care Providers.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same author

Maternal MLH3 dysfunction drives unexplained recurrent pregnancy loss via impaired oocyte maturation and defective decidualization.

Cellular and molecular life sciences : CMLS·2026
Same author

Linking FHIR-Based Medication Data to a Computable Algorithm for Heart Medication Optimization: A Critical Component of Any Medication Learning Health System.

Learning health systems·2026
Same author

Pharmacotherapeutic Controversies During Temperature Control After Out-of-Hospital Cardiac Arrest: A Semi-Structured Literature Review.

Pharmacotherapy·2026
Same author

Insulin resistance and SIK1 hyperactivation: implications for vascular remodeling in recurrent pregnancy loss.

American journal of physiology. Endocrinology and metabolism·2025
Same author

A prediction model of preterm birth in singleton pregnancy after assisted reproduction therapy.

BMC pregnancy and childbirth·2025

Related Experiment Video

Updated: Feb 8, 2026

Author Spotlight: A Streamlined Approach to Studying Cell Death Initiation in Hypersensitive Response
06:06

Author Spotlight: A Streamlined Approach to Studying Cell Death Initiation in Hypersensitive Response

Published on: November 10, 2023

2.0K

Initial study of clinical pharmacy work prioritization tools.

Allen Flynn1, Hanjie Mo2, Jerika V Nguyen3

  • 1Department of Learning Health Sciences, University of Michigan Medical School, Ann Arbor, MI ajflynn@med.umich.edu.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|June 27, 2018
PubMed
Summary
This summary is machine-generated.

Clinical pharmacy work prioritization tools (CPWPTs) show significant variation in their design and prioritization factors. While most tools are integrated into EHRs, empirical validation remains limited, highlighting a need for further development.

Keywords:
clinical pharmacy information systemsinformaticspatient acuitypharmacyprioritizationscoring methods

More Related Videos

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

2.0K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

996

Related Experiment Videos

Last Updated: Feb 8, 2026

Author Spotlight: A Streamlined Approach to Studying Cell Death Initiation in Hypersensitive Response
06:06

Author Spotlight: A Streamlined Approach to Studying Cell Death Initiation in Hypersensitive Response

Published on: November 10, 2023

2.0K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

2.0K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

996

Area of Science:

  • Health Informatics
  • Clinical Pharmacy
  • Pharmacoeconomics

Background:

  • Clinical pharmacy work prioritization tools (CPWPTs) are increasingly implemented to optimize pharmacist activities.
  • Understanding the development, implementation, and validation of these tools is crucial for effective practice management.

Purpose of the Study:

  • To analyze the development, implementation, and validity of clinical pharmacy work prioritization tools (CPWPTs).
  • To explore informatics pharmacists' perceptions regarding CPWPT design, validation, and practical application.

Main Methods:

  • Qualitative interviews were conducted with 19 informatics pharmacists responsible for CPWPT configuration.
  • Data collection included open-ended questions on CPWPT factors, validation, and use, alongside demographic and site-specific information.

Main Results:

  • CPWPTs are often integrated into electronic health record platforms, with diverse prioritization factors (patient-specific, medication classes, interventions).
  • Face validity was universally reported, but empirical validation was infrequent (4/19 respondents).
  • Informatics pharmacists perceive CPWPTs as mirroring practice, benefiting from consensus design, but face challenges with logic complexity and balancing task-oriented vs. patient-centric approaches.

Conclusions:

  • Early CPWPTs exhibit substantial variability in prioritization factors, reflecting the scope of clinical pharmacy practice.
  • The findings underscore the need for robust validation methods and a balanced approach in CPWPT design to fully support clinical pharmacy services.